UK & Europe AA Gill takes swipe at NICE in final column NHS initially denied late writer immunotherapy.
Debates & Insight Sponsored OMA at NICE: Unlocking Access One Year On A new report by health economist Leela Barham examines how NICE’s Office for Market Access has progressed after a year in operation.
Views & Analysis NICE’s Office for Market Access: is it unlocking value for p... Leela Barham considers how the OMA has progressed since its launch.
Views & Analysis Calls to end the silent epidemic of PTHP Campaigners want to raise awareness of post-traumatic hypopituitarism following a head injury.
Views & Analysis How can pharma help NHS improve mental health services? Sustainability and Transformation Plans present an opportunity for pharma to support research into mental health conditions.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
